Initiating levodopa/carbidopa therapy wi
β
Fabrizio Stocchi; Olivier Rascol; Karl Kieburtz; Werner Poewe; Joseph Jankovic;
π
Article
π
2010
π
John Wiley and Sons
π
English
β 180 KB
## Abstract ## Objective Lβdopa is the most widely used and most effective therapy for Parkinson disease (PD), but chronic treatment is associated with motor complications in the majority of patients. It has been hypothesized that providing more continuous delivery of Lβdopa to the brain would red